Industries > Pharma > Biobanking Market Report 2021-2031

Biobanking Market Report 2021-2031

Forecasts by Biobank Type (Standalone, Partnership), Application (Research, Therapeutics), Sample Type (Bio-fluids, Human Tissue/Tumor Cells, Stem Cells, DNA/RNA, Other Sample Types), Ownership (National/ Regional, Universities, Non-Profit, Private), Region (North America, Europe, Asia Pacific, LAMEA). PLUS Analysis of Leading Biobanking Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 21 October 2020
PAGES: 360
PRODUCT CODE: PHA0932

Clear
WOOCS 2.2.1
SKU: PHA0932 Categories: , , Tag:

Within clinical trials and therefore in the fight against COVID-19, biobanks will play an essential role. How can you and your organization be part of this?

The race for a COVID-19 solution is not just a race for profit or market share, but a race to save increased death, and rescue the global economy. Your company needs to be involved today.

What are the Market Opportunities & Threats? This report tells you NOW
• High Potential of Stem Cell Therapeutics in Unmet Clinical Needs
• Importance of Networking & Exchange Between Biobanks
• Growing Demand for Biobanked Samples for Preclinical Research
• Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
• Even with Government Funding, Biobanks Must Become Self Sufficient to Thrive Long-Term
• Public Concerns Over Confidentiality and Security Threaten Availability of Donors

UNIQUE COVID-19 VARIATIONS only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

Which Factors are Fueling Biobanking Industry Growth?
• Rising R&D Expenditure
• Growing Chronic Disease Burden
• Biobanks Are Critical for Cancer Research
• Government Funding to Fuel Market Growth

Which Factors are Restraining Growth?
• Legal & Ethical Challenges in Biobanking
• Lack of Standardization of Approval Required
• Issues in Developing Biobanks & Using Stored Specimens

To access the data contained in this document please email contactus@visiongain.com

How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. This report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks. You must read this.

Discover how to stay ahead
Our 360-page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking Market. See how to exploit opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Biobank Type
• Standalone
• Partnership

Application
• Research
• Therapeutics

Sample Type
• Bio-fluids
• Human Tissue/Tumor Cells
• Stem Cells
• DNA/RNA
• Other Sample Types

Ownership
• National/ Regional
• Universities
• Non-Profit
• Private

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 13 leading national markets:

By Region

• North America:
• U.S.
• Canada

• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Denmark
• Finland
• Rest of Europe

• Asia Pacific:
• China
• Japan
• India
• Rest of Asia Pacific

• LAMEA

Biobanking Market Report 2021-2031

Need industry data? Please contact us today.

Leading companies and the potential for market growth
Overall world revenue for Biobanking Market will surpass $xx billion in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Biobanking Market. Some of the companies profiled in this report include Thermo Fisher Scientific Inc., Merck & Co., QIAGEN, Danaher, STEMCELL Technologies Inc., BioLifeSolutions Inc., BioCision, VWR International, LLC., Hamilton Company, and Becton, Dickinson, and Company (BD).

Key Questions Answered by this Report:
• What is the current size of the overall global Biobanking market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall biobanking market over the next ten years?
• What are the main segments within the overall Biobanking market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world Biobanking? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Which are the leading companies and what are their activities, results, developments, and prospects?
• What are the main trends that will affect the world Biobanking market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• How will the global Biobanking market evolve over the forecasted period, 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is intended for everybody needing commercial analyses for the Global Biobanking Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Get our report today Biobanking Market Report 2021-2031: Forecasts by Biobank Type (Standalone, Partnership), Application (Research, Therapeutics), Sample Type (Bio-fluids, Human Tissue/Tumor Cells, Stem Cells, DNA/RNA, Other Sample Types), Ownership (National/ Regional, Universities, Non-Profit, Private), Region (North America, Europe, Asia Pacific, LAMEA). PLUS Analysis of Leading Biobanking Companies AND COVID-19 Recovery Scenarios.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geography/region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biobanking Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for Biobanking Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031

Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.

13 November 2020

READ

Visiongain Publishes Antihypertensive Drugs Market Report 2021-2031

Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.

13 November 2020

READ

Categories

Category